Can Clopidogrel reduce the risk of recurrent ischemic events, and what is its role in secondary prevention of thrombotic complications?
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Clopidogrel reduce the risk of recurrent ischemic events, and what is its role in secondary prevention of thrombotic complications?
Yes, Clopidogrel can reduce the risk of recurrent ischemic events by inhibiting platelet aggregation, thereby preventing thrombosis in arterial circulation.
Clopidogrel is used in secondary prevention of thrombotic complications by blocking the ADP receptor on platelets, reducing clot formation.
Yes, Clopidogrel lowers the risk of strokes and heart attacks in patients with past ischemic events by preventing platelet clumping.
Clopidogrel helps in secondary prevention of thrombotic events by irreversibly binding to platelet receptors, thus inhibiting clot formation.
By preventing platelet aggregation, Clopidogrel reduces the likelihood of recurrent ischemic events and is essential for secondary thrombotic risk management.